Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062647
Status:
COMPLETED
Last Update Posted:
2019-01-16
First Post:
2003-06-09
Brief Title:
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia
Sponsor:
Cumberland Pharmaceuticals
Organization:
Cumberland Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gram-Positive Bacterial Infections |
Keywords: